If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Thought Leader Services
Download FREE Excerpt
14 Info Graphics
29 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Key Opinion Leaders (KOLs) play a critical role in educating the medical and scientific communities to build awareness about the latest medical therapies and novel mechanisms of action. KOL relationship management has thus emerged as a necessary and vital part of organizational success.
In an effort to examine how leading pharmaceutical companies approach KOL management, this research by Best Practices, LLC identifies the key elements of KOL management excellence, from leadership structure and resource levels to relationship activities and social media usage/impact. Research findings provide industry metrics that can serve as a reference point for companies to improve their KOL management tactics.
Twenty-two benchmark survey respondents from 17 companies participated in this study. Nearly 33% are directors, senior directors or vice presidents, and 45% are based in the United States. The participants represent three different industries. About 68% work in medical and scientific affairs.
Biotech; Medical Device; Pharmaceutical; Health Care; Education; Science; Manufacturing; Consumer Products; Diagnostic; Chemical
Biogen Idec; Baxter Healthcare; Medtronic; Teva Pharmaceutical Industries Ltd; Ortho-Clinical Diagnostics; Torrent Pharmaceuticals Ltd.; Reliance Institute of Life Sciences; Lupin; Bayer; ViiV Healthcare; AstraZeneca; Onyx Pharmaceuticals; Johnson & Johnson; LEO Pharma; Abbvie; AUSA; Genentech